WellPoint (WLP) Announces Development of Innovative Drug Safety System Designed to Monitor Drug and Therapy Risks Post-FDA Approval

April 15, 2008 8:17 AM EDT Send to a Friend
HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login